Literature DB >> 1724992

NIK-247 blocks voltage-dependent ionic currents in crayfish axon.

J Kojima1, Y Sugawara, S Obara.   

Abstract

NIK-247 (9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]-quinoline hydrochloride hydrate), an acetylcholinesterase inhibitor, is structurally related to 4-aminopyridine (AP). Its effects on ionic currents were examined in the artificial node of the crayfish axon under voltage-clamp. When applied externally, NIK-247 reversibly suppressed both inward and outward currents. Effects on K currents were further studied in the presence of tetrodotoxin. NIK-247 suppressed the K current dose-dependently, but with an IC50 at of 10(-3) M. THA (9-amino-1,2,3,4-tetra-hydroacridine hydrochloride hydrate), a related inhibitor, similarly suppressed the K current with an IC50 of 5 x 10(-4) M, in comparison with 3-AP and 4-AP which had IC50's of 3 x 10(-5) M and at 10(-5) M, respectively. Furthermore, NIK-247 (and THA) suppressed the K current uniformly for the whole time course, whereas AP the AP's suppressed mainly the fast activating and inactivating K current with a voltage- and frequency-dependent recovery. Therefore, NIK-247 and THA seem to be neither potent nor very specific as ionic channel blockers. With respect to the K current, however, they clearly differ from the AP's in their mode of suppression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724992     DOI: 10.1254/jjp.57.545

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Nootropic agent vinpocetine blocks delayed rectified potassium currents more strongly than high-threshold calcium currents.

Authors:  E I Solntseva
Journal:  Neurosci Behav Physiol       Date:  1998 Mar-Apr

2.  Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction.

Authors:  Vladimir Bykov; Evgenia Gushchina; Sergey Morozov; Natalia Zhuravskaya; Kirill Kryshen; Valery Makarov; Aleksandr Matichin; Alena Zueva
Journal:  Sex Med       Date:  2022-01-08       Impact factor: 2.491

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.